Literature DB >> 16843109

Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark.

Mads Thomassen1, Anne-Marie Gerdes, Dorthe Cruger, Peter K A Jensen, Torben A Kruse.   

Abstract

Germline mutations in BRCA1 and BRCA2 predispose female carriers to breast and ovarian cancer. The majority of mutations identified are small deletions or insertions or are nonsense mutations. Large genomic rearrangements in BRCA1 are found with varying frequencies in different populations, but BRCA2 rearrangements have not been investigated thoroughly. The objective in this study was to determine the frequency of large genomic rearrangements in BRCA1 and BRCA2 in a large group of Danish families with increased risk of breast and ovarian cancer. A total of 617 families previously tested negative for mutations involving few bases were screened with multiplex ligation-dependent probe amplification (MLPA). Two deletions in BRCA1 were identified in three families; no large rearrangements were detected in BRCA2. The large deletions constitute 3.8% of the BRCA1 mutations identified, which is low compared to several other populations.

Entities:  

Mesh:

Year:  2006        PMID: 16843109     DOI: 10.1016/j.cancergencyto.2005.12.016

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  18 in total

1.  Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea.

Authors:  Ja Young Cho; Dae-Yeon Cho; Sei Hyun Ahn; Su-Youn Choi; Inkyung Shin; Hyun Gyu Park; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Bo Kyung Ku; Byung Ho Son
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

2.  Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population.

Authors:  Moon-Woo Seong; Sung Im Cho; Dong-Young Noh; Wonshik Han; Sung-Won Kim; Chul-Min Park; Hyun-Woong Park; So Yeon Kim; Ji Yeon Kim; Sung Sup Park
Journal:  Fam Cancer       Date:  2009-08-08       Impact factor: 2.375

3.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701

4.  Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

Authors:  Tal Distelman-Menachem; Tal Shapira; Yael Laitman; Bella Kaufman; Frida Barak; Sean Tavtigian; Eitan Friedman
Journal:  Fam Cancer       Date:  2008-09-17       Impact factor: 2.375

5.  Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.

Authors:  Helena Rudnicka; Tadeusz Debniak; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Jan Lubinski; Bohdan Gorski
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

6.  The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.

Authors:  Sarai Palanca; Inmaculada de Juan; Gema Perez-Simó; Eva Barragán; Isabel Chirivella; Eduardo Martínez; Oscar Fuster; Pascual Bolufer
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

7.  BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.

Authors:  Henriette Roed Nielsen; Mef Nilbert; Janne Petersen; Steen Ladelund; Mads Thomassen; Inge Søkilde Pedersen; Thomas V O Hansen; Anne-Bine Skytte; Åke Borg; Christina Therkildsen
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

8.  Genomic rearrangements in BRCA1 and BRCA2: A literature review.

Authors:  Ingrid Petroni Ewald; Patricia Lisboa Izetti Ribeiro; Edenir Inêz Palmero; Silvia Liliana Cossio; Roberto Giugliani; Patricia Ashton-Prolla
Journal:  Genet Mol Biol       Date:  2009-09-01       Impact factor: 1.771

9.  Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individuals.

Authors:  Sumadee De Silva; Kamani Hemamala Tennekoon; Eric Hamilton Karunanayake; Indrani Amarasinghe; Preethika Angunawela
Journal:  BMC Res Notes       Date:  2014-06-06

10.  Germline CDH1 deletions in hereditary diffuse gastric cancer families.

Authors:  Carla Oliveira; Janine Senz; Pardeep Kaurah; Hugo Pinheiro; Remo Sanges; Anne Haegert; Giovanni Corso; Jan Schouten; Rebecca Fitzgerald; Holger Vogelsang; Gisela Keller; Sarah Dwerryhouse; Donna Grimmer; Suet-Feung Chin; Han-Kwang Yang; Charles E Jackson; Raquel Seruca; Franco Roviello; Elia Stupka; Carlos Caldas; David Huntsman
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.